000			02110 a2200577 4500
005			20250514184157.0
264		0	_c20041221
008			200412s 0 0 eng d
022			_a1524-9557
024	7		_a10.1097/00002371-200405000-00009 _2doi
040			_aNLM _beng _cNLM
100	1		_aPantuck, Allan J
245	0	0	_aPhase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancer. _h[electronic resource]
260			_bJournal of immunotherapy (Hagerstown, Md. : 1997) _c
300			_a240-53 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAged
650	0	4	_aCD4 Antigens _xbiosynthesis
650	0	4	_aCD8 Antigens _xbiosynthesis
650	0	4	_aCancer Vaccines _xtherapeutic use
650	0	4	_aCell Separation
650	0	4	_aClinical Trials as Topic
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFlow Cytometry
650	0	4	_aGenetic Therapy _xmethods
650	0	4	_aGenetic Vectors
650	0	4	_aHumans
650	0	4	_aImmunotherapy
650	0	4	_aInterleukin-2 _xgenetics
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMucin-1 _xgenetics
650	0	4	_aPhenotype
650	0	4	_aProstatic Neoplasms _xtherapy
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aTh1 Cells
650	0	4	_aTime Factors
650	0	4	_aTumor Necrosis Factor-alpha _xmetabolism
650	0	4	_aUp-Regulation
650	0	4	_aVaccinia virus _xgenetics
700	1		_avan Ophoven, Arndt
700	1		_aGitlitz, Barbara J
700	1		_aTso, Cho-Lea
700	1		_aAcres, Bruce
700	1		_aSquiban, Patrick
700	1		_aRoss, Michael E
700	1		_aBelldegrun, Arie S
700	1		_aFiglin, Robert A
773	0		_tJournal of immunotherapy (Hagerstown, Md. : 1997) _gvol. 27 _gno. 3 _gp. 240-53
856	4	0	_uhttps://doi.org/10.1097/00002371-200405000-00009 _zAvailable from publisher's website
999			_c14790882 _d14790882